(FPE3) Fuchs Petrolub SE - Ratings and Ratios
Lubricants, Greases, Oils, Fluids
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.07% |
| Yield on Cost 5y | 2.94% |
| Yield CAGR 5y | 4.26% |
| Payout Consistency | 88.5% |
| Payout Ratio | 51.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 21.9% |
| Value at Risk 5%th | 32.8% |
| Relative Tail Risk | -8.75% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.06 |
| Alpha | -11.86 |
| CAGR/Max DD | 0.19 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.434 |
| Beta | 0.358 |
| Beta Downside | 0.431 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.59% |
| Mean DD | 8.26% |
| Median DD | 6.35% |
Description: FPE3 Fuchs Petrolub SE January 08, 2026
Fuchs SE (formerly Fuchs Petrolub SE) manufactures and distributes a broad portfolio of lubricants and functional fluids across automotive, industrial, aerospace, wind-energy, construction, mining and food sectors worldwide, serving markets in Europe, the Middle East, Africa, Asia-Pacific and the Americas.
Key growth drivers include global automotive production (especially electric-vehicle power-train lubrication), rising demand for biodegradable and food-grade greases in the sustainability-focused food industry, and expanding wind-energy capacity that fuels demand for high-performance hydraulic and turbine oils. Conversely, the segment is sensitive to base-oil price volatility and cyclical industrial output.
In FY 2023 the company reported revenue of roughly €2.5 billion with an adjusted EBITDA margin near 13 %, and a dividend yield of about 2.5 % on its preference shares. The balance sheet remains strong, with net debt below €300 million, giving it ample flexibility to invest in R&D and capacity expansion. These figures are based on the latest annual report; exact numbers may vary as the company finalises its 2024 results.
For a deeper quantitative view of Fuchs SE’s valuation metrics, the ValueRay platform offers a concise dashboard worth exploring.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (295.0m TTM) > 0 and > 6% of Revenue (6% = 213.5m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA -0.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 20.79% (prev 18.81%; Δ 1.98pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 382.0m > Net Income 295.0m (YES >=105%, WARN >=100%) |
| Net Debt (-142.0m) to EBITDA (530.0m) ratio: -0.27 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.19 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (131.0m) change vs 12m ago -0.23% (target <= -2.0% for YES) |
| Gross Margin 34.67% (prev 34.34%; Δ 0.33pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 136.0% (prev 135.4%; Δ 0.59pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 71.67 (EBITDA TTM 530.0m / Interest Expense TTM 6.00m) >= 6 (WARN >= 3) |
Altman Z'' 3.73
| (A) 0.28 = (Total Current Assets 1.36b - Total Current Liabilities 621.0m) / Total Assets 2.64b |
| (B) 0.09 = Retained Earnings (Balance) 228.0m / Total Assets 2.64b |
| (C) 0.16 = EBIT TTM 430.0m / Avg Total Assets 2.62b |
| (D) 0.48 = Book Value of Equity 359.0m / Total Liabilities 747.0m |
| Total Rating: 3.73 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 83.02
| 1. Piotroski 6.50pt |
| 2. FCF Yield 7.19% |
| 3. FCF Margin 9.16% |
| 4. Debt/Equity 0.06 |
| 5. Debt/Ebitda -0.27 |
| 6. ROIC - WACC (= 9.10)% |
| 7. RoE 15.61% |
| 8. Rev. Trend 57.02% |
| 9. EPS Trend 73.63% |
What is the price of FPE3 shares?
Over the past week, the price has changed by -0.31%, over one month by +1.27%, over three months by -0.94% and over the past year by -2.31%.
Is FPE3 a buy, sell or hold?
What are the forecasts/targets for the FPE3 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 49.6 | 30.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 40 | 4.9% |
FPE3 Fundamental Data Overview January 06, 2026
P/E Trailing = 17.1607
P/E Forward = 19.084
P/S = 1.2822
P/B = 2.6477
P/EG = 4.08
Beta = 0.838
Revenue TTM = 3.56b EUR
EBIT TTM = 430.0m EUR
EBITDA TTM = 530.0m EUR
Long Term Debt = 10.0m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 63.0m EUR (from shortTermDebt, last quarter)
Debt = 112.0m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -142.0m EUR (from netDebt column, last quarter)
Enterprise Value = 4.53b EUR (4.56b + Debt 112.0m - CCE 142.0m)
Interest Coverage Ratio = 71.67 (Ebit TTM 430.0m / Interest Expense TTM 6.00m)
FCF Yield = 7.19% (FCF TTM 326.0m / Enterprise Value 4.53b)
FCF Margin = 9.16% (FCF TTM 326.0m / Revenue TTM 3.56b)
Net Margin = 8.29% (Net Income TTM 295.0m / Revenue TTM 3.56b)
Gross Margin = 34.67% ((Revenue TTM 3.56b - Cost of Revenue TTM 2.33b) / Revenue TTM)
Gross Margin QoQ = 35.16% (prev 35.11%)
Tobins Q-Ratio = 1.72 (Enterprise Value 4.53b / Total Assets 2.64b)
Interest Expense / Debt = 1.79% (Interest Expense 2.00m / Debt 112.0m)
Taxrate = 26.96% (31.0m / 115.0m)
NOPAT = 314.1m (EBIT 430.0m * (1 - 26.96%))
Current Ratio = 2.19 (Total Current Assets 1.36b / Total Current Liabilities 621.0m)
Debt / Equity = 0.06 (Debt 112.0m / totalStockholderEquity, last quarter 1.89b)
Debt / EBITDA = -0.27 (Net Debt -142.0m / EBITDA 530.0m)
Debt / FCF = -0.44 (Net Debt -142.0m / FCF TTM 326.0m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.27% (Net Income 295.0m / Total Assets 2.64b)
RoE = 15.61% (Net Income TTM 295.0m / Total Stockholder Equity 1.89b)
RoCE = 22.63% (EBIT 430.0m / Capital Employed (Equity 1.89b + L.T.Debt 10.0m))
RoIC = 16.19% (NOPAT 314.1m / Invested Capital 1.94b)
WACC = 7.09% (E(4.56b)/V(4.68b) * Re(7.23%) + D(112.0m)/V(4.68b) * Rd(1.79%) * (1-Tc(0.27)))
Discount Rate = 7.23% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -0.78%
[DCF Debug] Terminal Value 83.95% ; FCFF base≈326.8m ; Y1≈391.7m ; Y5≈624.4m
Fair Price DCF = 200.3 (EV 12.98b - Net Debt -142.0m = Equity 13.12b / Shares 65.5m; r=7.09% [WACC]; 5y FCF grow 21.21% → 2.90% )
EPS Correlation: 73.63 | EPS CAGR: 12.67% | SUE: -1.02 | # QB: 0
Revenue Correlation: 57.02 | Revenue CAGR: 5.16% | SUE: 0.22 | # QB: 0
EPS next Year (2026-12-31): EPS=2.49 | Chg30d=-0.043 | Revisions Net=-2 | Growth EPS=+8.0% | Growth Revenue=+2.5%